Justin Sprengers

Truncated FGFR2 is a clinically actionable oncogene in multiple cancers

Daniel Zingg, Jinhyuk Bhin, Julia Yemelyanenko et al. · Nature · 2022 · 130 citations · Full text

Medicine, Genetics, Oncology +17

MYC is a clinically significant driver of mTOR inhibitor resistance in breast cancer

Jinhyuk Bhin, Julia Yemelyanenko, Xue Chao et al. · The Journal of Experimental Medicine · 2023 · 28 citations · Full text

Medicine, Cancer Biology, Oncology +17

QPCTL regulates macrophage and monocyte abundance and inflammatory signatures in the tumor microenvironment

Kaspar Bresser, Meike E. W. Logtenberg, Mireille Toebes et al. · OncoImmunology · 2022 · 19 citations · Full text

Medicine, Immunology, Oncology +17

Spontaneous early-onset neurodegeneration in the brainstem and spinal cord of NSG, NOG, and NXG mice

Giovanni Finesso, Elinor Willis, James C. Tarrant et al. · Veterinary Pathology · 2023 · 10 citations · Full text

Life Sciences, Neuroscience, Pathology +11

NASP modulates histone turnover to drive PARP inhibitor resistance

Sarah C. Moser, Anna Khalizieva, Josef Roehsner et al. · Nature · 2025 · 10 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +12